New ultrasound tech could spot brain disorders in newborns before symptoms appear
NCT ID NCT06940713
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 44 times
Summary
The CONEXUS study is testing a new type of brain imaging called functional ultrasound (fUS) in newborns at high risk for neurodevelopmental disorders. Researchers want to see if this painless, non-invasive technique can measure brain connectivity and detect early signs of problems. The study will include 76 babies across several hospitals in France.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATES AND PRETERM INFANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Robert Debré
RECRUITINGParis, 75019, France
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
functional ultrasound imaging (fUS) device
What this could lead to
If successful, this could provide a new, non-invasive way to detect early signs of brain development problems in newborns, potentially leading to earlier diagnosis and treatment.
What could go wrong
This is an early feasibility study with only 76 participants, so results may not apply to all babies. The technique is still experimental and may not prove reliable enough for routine use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.